MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Combined dystonia in a patient carrying a novel ATL1 gene variant.

M. Gea, K. Beyer, F. Nuñez, L. Ispierto, R. álvarez, G. Lucente, D. Vilas (Badalona, Spain)

Meeting: MDS Virtual Congress 2021

Abstract Number: 121

Keywords: Dystonia: Clinical features, Dystonia: Genetics

Category: Dystonia: Epidemiology, Genetics, Phenomenology

Objective: To describe a patient with a childhood-onset combined dystonia who was found to be a carrier of a novel mutation in the ATL1 gene.

Background: Combined dystonia is defined as a dystonia which appears along with other movement disorders such as myoclonus, chorea or parkinsonism. Dystonic postures may or may not be the predominant movement abnormalities. Variants in the ATL1 gene are associated with pure hereditary spastic paraplegia (HSP-ATL1), also known as SPG3A, with an autosomal dominant inheritance. HSP-ATL1 patients mostly present as early onset pure HSP, with rare cases presenting motor-sensory axonal neuropathy.

Method: A 43-year-old male presented with generalized choreiform movements in limbs and trunk, as well as craniocervical dystonia and proximal myoclonus. Strength and deep tendon reflexes were normal, and no pyramidal signs were observed. His father, brother and two paternal uncles had suffered from similar movements since childhood. Brain magnetic resonance showed marked symmetric atrophy of the basal ganglia, with involvement of the caudate, putaminal and globus pallidum nuclei. Cerebrospinal fluid, hematological, biochemical, autoimmunity and vitamin tests were unremarkable. A comprehensive electrophysiological study was normal.

Results: The patient was diagnosed with early onset persistent generalized combined dystonia with autosomal dominant inheritance. He was started on tetrabenazine with partial improvement but parkinsonism features arose. By genetic testing, the novel Y90H variant in the ATL1 gene was identified. Y90H is located within the a-helix-1 flanking a conserved GTPase motif, evolutionally highly conserved (PhyloP=8.04) and predicted to cause major functional disruption of atlastin (Polyphen=1.00). The other affected family members are not available for clinical evaluation or genetic testing so far.

Conclusion: Here we present a patient with a hereditary combined dystonia carrying a novel mutation in the ATL1 gene. Whether variants in this gene can cause some forms of combined dystonia should be further explored.

To cite this abstract in AMA style:

M. Gea, K. Beyer, F. Nuñez, L. Ispierto, R. álvarez, G. Lucente, D. Vilas. Combined dystonia in a patient carrying a novel ATL1 gene variant. [abstract]. Mov Disord. 2021; 36 (suppl 1). https://www.mdsabstracts.org/abstract/combined-dystonia-in-a-patient-carrying-a-novel-atl1-gene-variant/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2021

MDS Abstracts - https://www.mdsabstracts.org/abstract/combined-dystonia-in-a-patient-carrying-a-novel-atl1-gene-variant/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley